• Press Release

Deirdre J. Cohen, MD, MS, Appointed as Director of Gastrointestinal Oncology Program of Mount Sinai Health System

Will Also Head Cancer Clinical Trials Office at The Tisch Cancer Institute

  • New York, NY
  • (September 29, 2020)

Deirdre J. Cohen, MD, MS, an expert in pancreatic and other gastrointestinal cancers as well as an accomplished clinical trial leader has joined Mount Sinai Health System as Director of the Gastrointestinal (GI) Oncology Program and Medical Director of the Cancer Clinical Trials Office at The Tisch Cancer Institute.

Dr. Cohen will also be an Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. In these roles, she will conduct important translational and clinical research, including studies that build upon scientific discoveries developed at Mount Sinai and collaborating institutions.

As Director of the GI Oncology Program, Dr. Cohen will foster both clinical and research activities associated with GI cancers across the Mount Sinai cancer sites. She will also oversee the development of clinical trials in her role as Medical Director of the Cancer Clinical Trials Office. Dr. Cohen has abundant experience as Principal Investigator on numerous trials for novel therapeutic approaches for gastrointestinal cancer in particular.

“We are very proud that Dr. Cohen has decided to join us to help lead our efforts in gastrointestinal cancers,” said Ramon Parsons, MD, PhD, Director of The Tisch Cancer Institute at Mount Sinai, Chair of Oncological Sciences, and Ward-Coleman Professor in Cancer Research of the Icahn School of Medicine at Mount Sinai. “We are excited to welcome her to also further develop our already robust clinical trial office.” 

Prior to joining Mount Sinai, Dr. Cohen was on the faculty in the Division of Medical Oncology at New York University (NYU) for 13 years. Recently, she served as Medical Director for the Perlmutter Cancer Center Clinical Trials Office and Acting Director of NYU GI Medical Oncology. Board certified in internal medicine, medical oncology, and hematology, Dr. Cohen is a member of the American Society of Clinical Oncology and the National Cancer Institute Colon Task Force.

Dr. Cohen received her MD from SUNY Health Science Center at Brooklyn and a Master of Science in Clinical Investigation from New York University. She completed a residency in internal medicine at NewYork-Presbyterian/Weill Cornell Medical Center and a fellowship in hematology/oncology at NYU Langone School of Medicine.

“Dr. Cohen’s arrival is an exciting step forward for coordinating a multidisciplinary approach for gastrointestinal cancer that builds on a strong foundation already here,” said William K. Oh, MD, Chief of Hematology and Medical Oncology and Deputy Director of The Tisch Cancer Institute at Mount Sinai and the Ezra M. Greenspan, M.D. Professor in Clinical Cancer Care Therapeutics. “We are driven to continue to develop more effective therapies in trials for a constellation of cancers that take so many lives every year.” 


About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in 4 out of 10 pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.